Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco Products | 34 | 2024 | 197 | 10.140 |
Why?
|
| Alcohol Drinking | 21 | 2023 | 167 | 7.440 |
Why?
|
| Cannabis | 10 | 2024 | 46 | 5.120 |
Why?
|
| Substance-Related Disorders | 18 | 2023 | 185 | 4.650 |
Why?
|
| Tobacco Use Disorder | 12 | 2022 | 117 | 4.590 |
Why?
|
| Smoking Cessation | 22 | 2025 | 408 | 4.360 |
Why?
|
| Marijuana Smoking | 9 | 2023 | 34 | 4.350 |
Why?
|
| Cigarette Smoking | 13 | 2023 | 82 | 4.230 |
Why?
|
| Tobacco Use | 15 | 2025 | 99 | 3.970 |
Why?
|
| Smoking | 21 | 2023 | 473 | 3.880 |
Why?
|
| Menthol | 8 | 2022 | 18 | 3.360 |
Why?
|
| Electronic Nicotine Delivery Systems | 16 | 2023 | 204 | 3.260 |
Why?
|
| Sexual and Gender Minorities | 6 | 2025 | 51 | 2.770 |
Why?
|
| Marijuana Use | 10 | 2024 | 40 | 2.750 |
Why?
|
| Adolescent | 47 | 2025 | 3104 | 2.730 |
Why?
|
| Young Adult | 49 | 2025 | 2714 | 2.620 |
Why?
|
| Adult | 56 | 2025 | 7703 | 2.030 |
Why?
|
| Humans | 91 | 2025 | 27968 | 1.910 |
Why?
|
| Female | 63 | 2025 | 15074 | 1.750 |
Why?
|
| Alcoholism | 7 | 2018 | 119 | 1.750 |
Why?
|
| Tobacco Smoking | 4 | 2023 | 38 | 1.700 |
Why?
|
| Male | 59 | 2025 | 13424 | 1.670 |
Why?
|
| Prevalence | 15 | 2023 | 496 | 1.510 |
Why?
|
| United States | 27 | 2023 | 2139 | 1.510 |
Why?
|
| Smokers | 9 | 2022 | 126 | 1.430 |
Why?
|
| Motivation | 7 | 2025 | 212 | 1.370 |
Why?
|
| Depressive Disorder, Major | 5 | 2018 | 127 | 1.340 |
Why?
|
| Smoking Prevention | 5 | 2019 | 90 | 1.290 |
Why?
|
| Marketing | 7 | 2024 | 35 | 1.280 |
Why?
|
| Nicotine | 5 | 2022 | 86 | 1.130 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2017 | 4 | 1.070 |
Why?
|
| Internet | 9 | 2019 | 124 | 1.040 |
Why?
|
| Alcohol-Related Disorders | 3 | 2016 | 12 | 1.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2017 | 28 | 1.000 |
Why?
|
| Students | 5 | 2018 | 196 | 0.930 |
Why?
|
| Depression | 3 | 2018 | 215 | 0.910 |
Why?
|
| Social Media | 2 | 2018 | 54 | 0.900 |
Why?
|
| Cognition | 4 | 2021 | 322 | 0.890 |
Why?
|
| African Americans | 3 | 2022 | 352 | 0.890 |
Why?
|
| Risk Factors | 13 | 2021 | 2078 | 0.880 |
Why?
|
| Hallucinogens | 1 | 2024 | 14 | 0.860 |
Why?
|
| Comorbidity | 10 | 2023 | 257 | 0.860 |
Why?
|
| Rape | 2 | 2014 | 3 | 0.850 |
Why?
|
| Medical Marijuana | 1 | 2023 | 4 | 0.840 |
Why?
|
| Crime Victims | 2 | 2014 | 18 | 0.840 |
Why?
|
| Marijuana Abuse | 3 | 2019 | 14 | 0.820 |
Why?
|
| Ecological Momentary Assessment | 2 | 2022 | 51 | 0.810 |
Why?
|
| Middle Aged | 23 | 2025 | 7111 | 0.810 |
Why?
|
| Affect | 2 | 2014 | 85 | 0.790 |
Why?
|
| Telemedicine | 3 | 2025 | 174 | 0.790 |
Why?
|
| Social Networking | 3 | 2018 | 9 | 0.790 |
Why?
|
| Social Support | 3 | 2017 | 125 | 0.780 |
Why?
|
| Risk-Taking | 3 | 2017 | 61 | 0.770 |
Why?
|
| Surveys and Questionnaires | 9 | 2024 | 967 | 0.760 |
Why?
|
| Urban Population | 2 | 2025 | 78 | 0.740 |
Why?
|
| Adolescent Behavior | 2 | 2019 | 68 | 0.730 |
Why?
|
| Vaping | 5 | 2023 | 129 | 0.730 |
Why?
|
| Harm Reduction | 3 | 2019 | 8 | 0.700 |
Why?
|
| Legislation, Drug | 2 | 2018 | 6 | 0.680 |
Why?
|
| Intention | 3 | 2021 | 76 | 0.660 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 31 | 0.630 |
Why?
|
| Reward | 1 | 2019 | 45 | 0.630 |
Why?
|
| HIV Infections | 2 | 2023 | 157 | 0.620 |
Why?
|
| Heterosexuality | 3 | 2024 | 19 | 0.610 |
Why?
|
| Tobacco | 4 | 2022 | 87 | 0.610 |
Why?
|
| Mental Disorders | 2 | 2018 | 110 | 0.600 |
Why?
|
| Smoking Water Pipes | 2 | 2019 | 3 | 0.580 |
Why?
|
| Universities | 4 | 2014 | 120 | 0.580 |
Why?
|
| Racism | 1 | 2018 | 11 | 0.580 |
Why?
|
| Child | 8 | 2023 | 2225 | 0.570 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 96 | 0.570 |
Why?
|
| Ethanol | 3 | 2018 | 123 | 0.550 |
Why?
|
| Anxiety | 1 | 2018 | 148 | 0.550 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 414 | 0.530 |
Why?
|
| Neoplasms | 2 | 2024 | 803 | 0.530 |
Why?
|
| Health Promotion | 4 | 2025 | 176 | 0.520 |
Why?
|
| Logistic Models | 5 | 2021 | 407 | 0.520 |
Why?
|
| Minority Groups | 4 | 2025 | 70 | 0.510 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 69 | 0.500 |
Why?
|
| Text Messaging | 3 | 2021 | 22 | 0.490 |
Why?
|
| Health Surveys | 4 | 2018 | 82 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2019 | 293 | 0.480 |
Why?
|
| Cohort Studies | 7 | 2019 | 884 | 0.480 |
Why?
|
| Aged | 12 | 2024 | 5383 | 0.480 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 94 | 0.470 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 118 | 0.470 |
Why?
|
| Self Efficacy | 1 | 2015 | 77 | 0.450 |
Why?
|
| Mental Health | 4 | 2024 | 99 | 0.440 |
Why?
|
| New England | 3 | 2019 | 8 | 0.440 |
Why?
|
| Depressive Disorder | 2 | 2011 | 55 | 0.420 |
Why?
|
| Women's Health | 2 | 2017 | 60 | 0.420 |
Why?
|
| Stress, Psychological | 3 | 2025 | 221 | 0.410 |
Why?
|
| Battered Women | 1 | 2012 | 2 | 0.400 |
Why?
|
| Residence Characteristics | 2 | 2024 | 102 | 0.400 |
Why?
|
| Truth Disclosure | 1 | 2012 | 25 | 0.400 |
Why?
|
| Association Learning | 1 | 2012 | 9 | 0.390 |
Why?
|
| Oklahoma | 3 | 2025 | 993 | 0.380 |
Why?
|
| Flavoring Agents | 3 | 2021 | 15 | 0.370 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 45 | 0.360 |
Why?
|
| Homeless Persons | 2 | 2022 | 113 | 0.330 |
Why?
|
| Tobacco, Smokeless | 3 | 2021 | 43 | 0.330 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 302 | 0.320 |
Why?
|
| Sexual Behavior | 4 | 2023 | 91 | 0.320 |
Why?
|
| Age Factors | 4 | 2019 | 733 | 0.300 |
Why?
|
| Drug Users | 2 | 2019 | 11 | 0.300 |
Why?
|
| Craving | 2 | 2017 | 18 | 0.270 |
Why?
|
| Health Behavior | 3 | 2019 | 158 | 0.260 |
Why?
|
| Feasibility Studies | 2 | 2025 | 193 | 0.250 |
Why?
|
| Sex Factors | 2 | 2019 | 465 | 0.250 |
Why?
|
| Pilot Projects | 2 | 2018 | 430 | 0.250 |
Why?
|
| Commerce | 2 | 2024 | 52 | 0.240 |
Why?
|
| Time Factors | 2 | 2023 | 1590 | 0.240 |
Why?
|
| Models, Psychological | 2 | 2018 | 81 | 0.240 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2016 | 40 | 0.240 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2024 | 6 | 0.220 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 243 | 0.220 |
Why?
|
| Rural Population | 1 | 2025 | 108 | 0.220 |
Why?
|
| Interprofessional Relations | 1 | 2023 | 66 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 97 | 0.200 |
Why?
|
| Tobacco Industry | 2 | 2024 | 33 | 0.200 |
Why?
|
| Physicians | 1 | 2023 | 83 | 0.190 |
Why?
|
| Machine Learning | 2 | 2021 | 84 | 0.190 |
Why?
|
| Smoke | 1 | 2021 | 37 | 0.180 |
Why?
|
| Underage Drinking | 2 | 2018 | 5 | 0.180 |
Why?
|
| Quality of Life | 1 | 2024 | 484 | 0.170 |
Why?
|
| Exercise | 1 | 2025 | 478 | 0.170 |
Why?
|
| Veterans | 1 | 2021 | 69 | 0.170 |
Why?
|
| Probability | 1 | 2019 | 78 | 0.160 |
Why?
|
| Economics, Behavioral | 1 | 2019 | 2 | 0.160 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 12 | 0.160 |
Why?
|
| Automobile Driving | 1 | 2019 | 9 | 0.160 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 957 | 0.160 |
Why?
|
| Odds Ratio | 1 | 2019 | 236 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 353 | 0.160 |
Why?
|
| Taste | 1 | 2019 | 26 | 0.160 |
Why?
|
| Patient Preference | 1 | 2019 | 32 | 0.150 |
Why?
|
| Nicotinic Agonists | 1 | 2018 | 3 | 0.150 |
Why?
|
| Virginia | 1 | 2018 | 4 | 0.150 |
Why?
|
| Alcoholic Beverages | 1 | 2018 | 4 | 0.150 |
Why?
|
| Peer Group | 1 | 2018 | 37 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2018 | 86 | 0.150 |
Why?
|
| Water Pipe Smoking | 1 | 2017 | 8 | 0.140 |
Why?
|
| Research | 1 | 2018 | 91 | 0.140 |
Why?
|
| Attitude to Health | 1 | 2018 | 89 | 0.140 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 46 | 0.140 |
Why?
|
| Public Health | 1 | 2018 | 89 | 0.140 |
Why?
|
| Criminals | 1 | 2017 | 2 | 0.140 |
Why?
|
| Taxes | 1 | 2017 | 12 | 0.140 |
Why?
|
| Alcohol Abstinence | 1 | 2017 | 3 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2018 | 96 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2017 | 67 | 0.140 |
Why?
|
| Smoke-Free Policy | 1 | 2017 | 17 | 0.140 |
Why?
|
| Central Nervous System Depressants | 2 | 2018 | 13 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 113 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2017 | 156 | 0.130 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 5 | 0.130 |
Why?
|
| Public Opinion | 1 | 2016 | 8 | 0.130 |
Why?
|
| Camptothecin | 1 | 2016 | 16 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 474 | 0.130 |
Why?
|
| Product Labeling | 1 | 2016 | 10 | 0.130 |
Why?
|
| Consumer Behavior | 1 | 2016 | 14 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 122 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 63 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2016 | 46 | 0.130 |
Why?
|
| Methadone | 1 | 2016 | 17 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2017 | 190 | 0.130 |
Why?
|
| Income | 1 | 2015 | 38 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2016 | 75 | 0.120 |
Why?
|
| Masculinity | 1 | 2014 | 1 | 0.120 |
Why?
|
| Role | 1 | 2014 | 6 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 138 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 329 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 105 | 0.110 |
Why?
|
| Association | 1 | 2013 | 4 | 0.110 |
Why?
|
| Research Design | 1 | 2015 | 183 | 0.110 |
Why?
|
| Linear Models | 1 | 2013 | 202 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 391 | 0.100 |
Why?
|
| Police | 1 | 2012 | 5 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2012 | 24 | 0.100 |
Why?
|
| Alcoholic Intoxication | 1 | 2012 | 4 | 0.100 |
Why?
|
| Shame | 1 | 2012 | 6 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 407 | 0.100 |
Why?
|
| Social Perception | 1 | 2012 | 23 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 769 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 46 | 0.100 |
Why?
|
| Psychological Tests | 1 | 2012 | 21 | 0.100 |
Why?
|
| Avoidance Learning | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cues | 1 | 2012 | 40 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 210 | 0.090 |
Why?
|
| Cell Phone | 1 | 2011 | 20 | 0.090 |
Why?
|
| Computers, Handheld | 1 | 2011 | 13 | 0.090 |
Why?
|
| Self Disclosure | 1 | 2010 | 6 | 0.080 |
Why?
|
| Friends | 1 | 2010 | 14 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2011 | 172 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2018 | 1244 | 0.080 |
Why?
|
| Gender Identity | 2 | 2022 | 25 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 472 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 248 | 0.070 |
Why?
|
| District of Columbia | 1 | 2024 | 10 | 0.060 |
Why?
|
| Anthropology, Cultural | 1 | 2023 | 4 | 0.050 |
Why?
|
| Recurrence | 2 | 2017 | 321 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2023 | 49 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2023 | 76 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2023 | 80 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 117 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 2367 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 610 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 44 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 148 | 0.040 |
Why?
|
| Social Identification | 1 | 2017 | 4 | 0.040 |
Why?
|
| Self Report | 1 | 2018 | 120 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 40 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Cotinine | 1 | 2017 | 45 | 0.030 |
Why?
|
| Saliva | 1 | 2017 | 96 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2017 | 60 | 0.030 |
Why?
|
| Leucovorin | 1 | 2016 | 19 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2016 | 58 | 0.030 |
Why?
|
| Crowdsourcing | 1 | 2016 | 4 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 88 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2016 | 55 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 194 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 237 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 719 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 160 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 143 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 414 | 0.030 |
Why?
|
| Social Norms | 1 | 2014 | 12 | 0.030 |
Why?
|
| Anger | 1 | 2014 | 15 | 0.030 |
Why?
|
| Personality | 1 | 2014 | 25 | 0.030 |
Why?
|
| Psychological Theory | 1 | 2014 | 30 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 381 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2541 | 0.030 |
Why?
|
| Psychometrics | 1 | 2014 | 121 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 756 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 843 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2015 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2010 | 4 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 58 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 10370 | 0.010 |
Why?
|